Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like Addex, Indivior Forge $335M Addiction Disorder Tie-Up January 2, 2018 DelMar Pharma Announces Fiscal Year 2017 Financial Results September 28, 2017 LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer March 29, 2017
